ATE441410T1 - Fenofibrattabletten - Google Patents
FenofibrattablettenInfo
- Publication number
- ATE441410T1 ATE441410T1 AT02700354T AT02700354T ATE441410T1 AT E441410 T1 ATE441410 T1 AT E441410T1 AT 02700354 T AT02700354 T AT 02700354T AT 02700354 T AT02700354 T AT 02700354T AT E441410 T1 ATE441410 T1 AT E441410T1
- Authority
- AT
- Austria
- Prior art keywords
- fenofibrate
- mixture
- weight
- tablet
- formulation
- Prior art date
Links
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 title abstract 4
- 229960002297 fenofibrate Drugs 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 238000009472 formulation Methods 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
- -1 C12 disaccharides Chemical class 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000012439 solid excipient Substances 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0100833A FR2819720B1 (fr) | 2001-01-22 | 2001-01-22 | Nouveaux comprimes de fenofibrate |
| PCT/FR2002/000245 WO2002056881A1 (fr) | 2001-01-22 | 2002-01-22 | Comprimes de fenofibrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE441410T1 true ATE441410T1 (de) | 2009-09-15 |
Family
ID=8859102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02700354T ATE441410T1 (de) | 2001-01-22 | 2002-01-22 | Fenofibrattabletten |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20040115264A1 (de) |
| EP (1) | EP1353663B1 (de) |
| JP (1) | JP4856843B2 (de) |
| AT (1) | ATE441410T1 (de) |
| CA (1) | CA2435714C (de) |
| DE (1) | DE60233552D1 (de) |
| ES (1) | ES2332880T3 (de) |
| FR (1) | FR2819720B1 (de) |
| WO (1) | WO2002056881A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000030616A1 (en) | 1998-11-20 | 2000-06-02 | Rtp Pharma Inc. | Dispersible phospholipid stabilized microparticles |
| US8586094B2 (en) | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
| JP2005535582A (ja) * | 2002-05-03 | 2005-11-24 | スカイファーマ・カナダ・インコーポレーテッド | 被覆錠剤 |
| WO2004028506A1 (en) * | 2002-09-24 | 2004-04-08 | Ranbaxy Laboratories Limited | Oral pharmaceutical compositions of fenofibrate having high bioavailability |
| FR2851734B1 (fr) * | 2003-02-28 | 2006-06-09 | Galenix Innovations | Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede |
| JPWO2005065715A1 (ja) * | 2003-12-25 | 2007-07-26 | 武田薬品工業株式会社 | 造粒性改善方法 |
| KR100654421B1 (ko) * | 2004-12-07 | 2006-12-06 | 삼성정밀화학 주식회사 | 효소분해 저항성 향상된 히드록시알킬셀룰로오스 유도체의제조방법 |
| JP2006273849A (ja) * | 2005-03-02 | 2006-10-12 | Aska Pharmaceutical Co Ltd | フェノフィブラート含有組成物 |
| JP4955685B2 (ja) | 2005-09-12 | 2012-06-20 | アクテリオン ファーマシューティカルズ リミテッド | ピリミジン−スルファミドを含む安定な医薬組成物 |
| US20110097414A1 (en) * | 2007-02-26 | 2011-04-28 | Sandal Roshan Lal | Pharmaceutical compositions comprising adsorbate of fenofibrate |
| MX2010001837A (es) | 2007-08-17 | 2010-03-10 | Actelion Pharmaceuticals Ltd | Derivados de 4-pirimidinasulfamida. |
| IL188647A0 (en) | 2008-01-08 | 2008-11-03 | Orina Gribova | Adaptable structured drug and supplements administration system (for oral and/or transdermal applications) |
| US9060932B2 (en) | 2009-07-09 | 2015-06-23 | Oshadi Drug Administration Ltd. | Matrix carrier compositions, methods and uses |
| WO2012005340A1 (ja) * | 2010-07-07 | 2012-01-12 | 日本たばこ産業株式会社 | クエン酸第二鉄を含む錠剤 |
| WO2014091318A1 (en) | 2012-12-11 | 2014-06-19 | Lupin Atlantis Holdings, S.A. | Reduced dose pharmaceutical compositions of fenofibrate |
| JP2020105174A (ja) * | 2018-12-27 | 2020-07-09 | 興和株式会社 | 医薬組成物 |
| IT202300027246A1 (it) * | 2023-12-19 | 2025-06-19 | Angelini Pharma S P A | Matrici farmaceutiche per il rilascio prolungato di farmaci |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2494112B1 (de) | 1980-11-19 | 1986-01-10 | Laruelle Claude | |
| FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| FR2722984B1 (fr) * | 1994-07-26 | 1996-10-18 | Effik Lab | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
| SI9500173B (sl) * | 1995-05-19 | 2002-02-28 | Lek, | Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo |
| FR2737121B1 (fr) * | 1995-07-27 | 1997-10-03 | Cl Pharma | Nouvelles formulations galeniques du fenofibrate et leurs applications |
| US6007570A (en) * | 1996-08-13 | 1999-12-28 | Oratec Interventions, Inc. | Apparatus with functional element for performing function upon intervertebral discs |
| DE19608750A1 (de) * | 1996-03-06 | 1997-09-11 | Durachemie Gmbh & Co Kg | Verfahren zur Herstellung von Fenofibrat-Präparaten |
| FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
| CA2214895C (en) | 1997-09-19 | 1999-04-20 | Bernard Charles Sherman | Improved pharmaceutical composition comprising fenofibrate |
| FR2783421B1 (fr) | 1998-09-17 | 2000-11-24 | Cll Pharma | Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications |
| EP1133280A1 (de) | 1998-11-20 | 2001-09-19 | RTP Pharma Inc. | Verfahren zur herstellung stabiler suspensionen von unlöslichen mikropartikeln |
| JP2002540174A (ja) | 1999-03-31 | 2002-11-26 | アボット・ラボラトリーズ | 脂質調節剤を含有する新規製剤 |
| FR2795961B1 (fr) * | 1999-07-09 | 2004-05-28 | Ethypharm Lab Prod Ethiques | Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation |
-
2001
- 2001-01-22 FR FR0100833A patent/FR2819720B1/fr not_active Expired - Fee Related
-
2002
- 2002-01-22 EP EP02700354A patent/EP1353663B1/de not_active Expired - Lifetime
- 2002-01-22 DE DE60233552T patent/DE60233552D1/de not_active Expired - Lifetime
- 2002-01-22 US US10/466,962 patent/US20040115264A1/en not_active Abandoned
- 2002-01-22 ES ES02700354T patent/ES2332880T3/es not_active Expired - Lifetime
- 2002-01-22 AT AT02700354T patent/ATE441410T1/de not_active IP Right Cessation
- 2002-01-22 WO PCT/FR2002/000245 patent/WO2002056881A1/fr not_active Ceased
- 2002-01-22 CA CA2435714A patent/CA2435714C/en not_active Expired - Fee Related
- 2002-01-22 JP JP2002557389A patent/JP4856843B2/ja not_active Expired - Fee Related
-
2009
- 2009-10-21 US US12/603,341 patent/US7976869B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7976869B2 (en) | 2011-07-12 |
| CA2435714A1 (en) | 2002-07-25 |
| FR2819720A1 (fr) | 2002-07-26 |
| WO2002056881A1 (fr) | 2002-07-25 |
| CA2435714C (en) | 2011-02-22 |
| ES2332880T3 (es) | 2010-02-15 |
| US20100040682A1 (en) | 2010-02-18 |
| EP1353663B1 (de) | 2009-09-02 |
| JP2004525887A (ja) | 2004-08-26 |
| WO2002056881A8 (fr) | 2004-05-06 |
| FR2819720B1 (fr) | 2004-03-12 |
| US20040115264A1 (en) | 2004-06-17 |
| DE60233552D1 (de) | 2009-10-15 |
| EP1353663A1 (de) | 2003-10-22 |
| JP4856843B2 (ja) | 2012-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE441410T1 (de) | Fenofibrattabletten | |
| RU2744432C2 (ru) | Фармацевтическая композиция, включающая ингибитор янус-киназы или его фармацевтически приемлемую соль | |
| EA200500891A1 (ru) | Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание | |
| ATE478841T1 (de) | Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung | |
| HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
| EA199800936A1 (ru) | Грануляты гидролизованной целлюлозы для фармацевтических препаратов | |
| MXPA04007427A (es) | Formulaciones de azitromicina granuladas por via seca. | |
| KR950007841A (ko) | 트라마돌 염을 함유하는 서방성 약물 제제 | |
| DK1327440T3 (da) | Orale præparater med gunstige nedbrydningsegenskaber | |
| WO2002065979A3 (en) | (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes | |
| PL364598A1 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
| EA200301040A1 (ru) | Способ производства фармацевтической композиции низкой дозы | |
| MXPA04003346A (es) | Formulacion de dosis oral de disolucion instantanea. | |
| SE0102440D0 (sv) | New compound | |
| KR900004326A (ko) | 디히드로에르고톡신 및 그의 산 부가염의 분산성 정제 | |
| WO2005065639A3 (en) | Novel pharmaceutical compositions | |
| HUP9801128A2 (hu) | Fukopeptidek, eljárás azok előállítására és alkalmazására, valamint ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
| AU2002214336A1 (en) | Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease | |
| EA200201024A1 (ru) | Фармацевтические композиции, содержащие олигосахариды, и их получение | |
| CA2373962A1 (en) | Immediate release medicinal compositions for oral use | |
| JP4291962B2 (ja) | 安定な甲状腺ホルモン含有固形製剤組成物 | |
| HUP0004701A2 (hu) | Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| CA2454449A1 (en) | Synergistic filler composition of pvp-va and silicified mycrocrystalline cellulose for tablet dosage form | |
| JP2003137778A (ja) | 医薬組成物及び医薬品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |